Scott Tarriff

Insider Reports History

Entity
Individual
Location
28 Tudor Rose Terrace, Mahwah, NJ
Signature
/s/ Scott Tarriff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Tarriff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EAGLE PHARMACEUTICALS, INC. 10%+ Owner Common Stock 993K $6.22M $6.27 Feb 28, 2024 By Tarriff 2016 Generation Skipping Exempt Family Trust DTD 12/28/2016
EAGLE PHARMACEUTICALS, INC. 10%+ Owner Common Stock 461K $2.89M $6.27 Feb 28, 2024 Direct

Insider Reports Filed by Scott Tarriff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EGRX EAGLE PHARMACEUTICALS, INC. Feb 28, 2024 1 -$13.3K 4 Mar 1, 2024 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Feb 27, 2024 2 -$20.3K 4 Feb 29, 2024 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Jan 5, 2024 1 -$22.2K 4 Jan 9, 2024 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Nov 1, 2023 2 -$299K 4 Nov 3, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Oct 2, 2023 3 -$300K 4 Oct 4, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. May 16, 2023 1 -$300K 4 May 18, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. May 11, 2023 5 -$931K 4 May 15, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Feb 28, 2023 2 -$87.2K 4 Mar 2, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Jan 23, 2023 1 -$126K 4 Jan 24, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Jan 5, 2023 1 -$112K 4 Jan 9, 2023 CEO, Director, 10%+ Owner
EGRX EAGLE PHARMACEUTICALS, INC. Feb 28, 2022 1 $0 4 Mar 2, 2022 CEO, Director, 10%+ Owner